I think there was marginal concern that there wasn't a Randomized component in the trials. Borderline unethical to be conducted on kids, adults would be the way to go: two birds with one stone really - further efficacy data for the kids and data for extension to adults.
MSB to dispute FDA finding in Type A meeting, page-20
-
- There are more pages in this discussion • 998 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
0.020(2.11%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 94.5¢ | 98.0¢ | 93.5¢ | $3.680M | 3.810M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 149921 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 60000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |